Porcine B-cell activating factor promotes anti-FMDV antibodies in vitro but not in vivo after DNA vaccination of pigs

Veterinary Immunology and Immunopathology

Volumn 120, Issue 3-4, 2007, Pages 115-123

  Bergamin, Fabio ^a   Saurer, Leslie ^a   Neuhaus, Viviane ^a   McCullough, Kenneth C ^a   Summerfield, Artur ^a  

^a INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

Author keywords

Antibody response; BAFF; DNA vaccination; Foot and mouth disease virus; Genetic adjuvant

Indexed keywords

ALPHA INTERFERON; ANTIGEN; DNA; DNA VACCINE; GAMMA INTERFERON; RECOMBINANT PROTEIN; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; JET INJECTION; MAMMAL CELL; MEMORY CELL; METHODOLOGY; MOLECULAR CLONING; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SEROCONVERSION; SERODIAGNOSIS; SWINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; B-CELL ACTIVATING FACTOR; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION REGULATION; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; VACCINES, DNA; VIRAL VACCINES;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; MAMMALIA; SUIDAE; SUS;

EID: 35448950496     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.06.021     Document Type: Article

References (25)

1. Andrew M., Morris K., Coupar B., Sproat K., Oke P., Bruce M., Broadway M., Morrissy C., and Strom D. Porcine interleukin-3 enhances DNA vaccination against classical swine fever. Vaccine 24 (2006) 3241-3247
2. Baizer L., Hayes J., Lacey C., and D'Antonio L. Needle-free injectors: advantages, current technologies, and future innovations. Pharm. Manuf. Packing Source (2002) 96-100
3. Carrasco C.P., Ridgen R.C., Schaffner R., Gerber H., Neuhaus V., Inumaru S., Takamatsu H., Bertoni G., McCullough K.C., and Summerfield A. Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology 104 (2001) 175-184
4. Cedillo-Barrón L., Foster-Cuevas M., Belsham G.J., Levèvre F., and Parkhouse R.M. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J. Gen. Virol. 82 (2001) 1713-1724
5. Do R.K., Hatada E., Lee H., Tourigny M.R., Hilbert D., and Chen-Kiang S. Attenuation of apoptosis underlies B-lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192 (2000) 953-964
6. Doel T.R. FMD vaccines. Virus Res. 91 (2003) 81-99
7. Guzylack-Piriou L., Balmelli C., McCullough K.C., and Summerfield A. Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12. Immunology 112 (2004) 28-37
8. Haig D.M., Hutchnson G., Green I., Sargan D., and Reid H.W. The effect of intradermal injection of GM-CSF and TNF-alpha on the accumulation of dendritic cells in ovine skin. Vet. Dermatol. 6 (1995) 211-220
9. Larsen D.L. Effects of DNA dose, route of vaccination, and co-administration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs. Am. J. Vet. Res. 63 (2002) 653-659
10. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., and Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3 (2002) 822-829
11. McCullough K.C., Bruckner L., Schaffner R., Fraefel W., Muller H.K., and Kihm U. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet. Microbiol. 30 (1992) 99-112
12. Nakayama K. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327 (1997) 625-635
13. Nardelli B., Belvedere O., Roschke V., Moore P.A., Olsen H.S., Mignone T.S., Sosnovtseva S., Carrell J.A., Feng P., Giri J.G., and Hilbert D.M. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97 (2001) 198-204
14. Niborski V., Li Y., Brennan F., Lane M., Torche A.M., Remond M., Bonneau M., Riffault S., Stirling C., Hutchings G., Takamatsu H., Barnett P., Charley B., and Schwartz-Cornil I. Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV. Vaccine 24 (2006) 7204-7214
15. Qi H., Egen J.G., Huang A.Y., and Germain R.N. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312 (2006) 1672-1676
16. Recher M., Lang K.S., Hunziker L., Freigang S., Eschli B., Harris N.L., Navarini A., Senn B.M., Fink K., Lotscher M., Hangartner L., Zellweger R., Hersberger M., Theocharides A., Hengartner H., and Zinkernagel R.M. Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat. Immunol. 5 (2004) 878-880
17. Ridgen R.C., Carrasco C.P., Barnett P.V., Summerfield A., and McCullough K.C. Innate immune responses following emergency vaccination against foot-and-mouth disease virus in pigs. Vaccine 21 (2003) 1466-1477
18. Rolink A.G., and Melchers F. BAFFled B cells survive and thrive: roles of BAFF in B-cell development. Curr. Opin. Immunol. 14 (2002) 266-275
19. Rompato G., Ling E., Chen Z., Van Kruiningen H., and Garmendia A.E. Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine. Vet. Immunol. Immunopathol. 109 (2006) 151-160
20. Scheerlinck J.Y. Genetic adjuvants for DNA vaccines. Vaccine 19 (2001) 2647-2656
21. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R.H., Browning J.L., and Tschopp J. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189 (1999) 1747-1756
22. Sutmoller P., and Vieira A. The relationship of neutralising antibody titres for FMDV and protection of cattle. Bol. Cent. Panamer. Fiebre Aftosa 39-40 (1980) 57
23. van Bekkum J.G. Correlation between serum antibody level and protection against challenge with FMD. Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of FMD (1969), Food and Agriculture Organisation, Rome 38
24. Wienhold D., Armengol E., Marquardt A., Marquardt C., Voigt H., Büttner M., Saalmüller A., and Pfaff E. Immunomodulatory effect of plasmids co-expressing cytokines in classical swine fever virus subunit gp55/E2-DNA vaccination. Vet. Res. 36 (2005) 571-587
25. Wong H.T., Cheng S.C., Sin F.W., Chan E.W., Sheng Z.T., and Xie Y. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine 20 (2002) 2641-2647